Related Experiment Video
Updated: Aug 19, 2026

Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Parenteral nutrition associated liver disease
Stuart S Kaufman1, Gabriel E Gondolesi, Thomas M Fishbein
1Department of Gastroenterology and Nutrition, Children's National Medical Center, 111 Michigan Avenue, N.W. Washington, DC 20010, USA. skaufman@cnmc.org
Insights
Parenteral nutrition (PN) can cause liver disease, especially in infants. New treatments are needed as current options are limited to intestinal adaptation or transplantation.
Area of Science:
- Gastroenterology and Hepatology
- Pediatric Nutrition
- Clinical Research
Background:
- Parenteral nutrition (PN)-associated liver disease (PNALD) is a common complication, particularly in infants.
- Cholestasis is the predominant form, ranging from mild bilirubin increases to fatal liver failure.
- Disease severity correlates with the underlying intestinal issue necessitating PN.
Purpose of the Study:
- To review the current understanding of PNALD pathogenesis and clinical presentation.
- To highlight the limitations of existing management strategies for PNALD.
- To emphasize the need for novel therapeutic interventions.
Main Methods:
- Review of existing literature on PNALD.
- Analysis of factors influencing disease severity.
- Discussion of current and potential treatment modalities.
Main Results:
- PNALD severity is linked to the extent of intestinal dysfunction and complications like sepsis.
- Current treatments are limited, with intestinal adaptation or transplantation being the only definitive options.
- The pathogenesis of PNALD remains incompletely understood.
Conclusions:
- Effective, less invasive treatments for PNALD are urgently required.
- Further research, including prospective trials of novel therapies, is crucial for improving patient outcomes.
- Addressing the underlying intestinal problem is key to managing PNALD.
Abstract:
Liver disease is relatively common during parenteral nutrition (PN). Cholestasis predominates in infants, and ranges in severity from mild increases in plasma conjugated bilirubin to progressive liver failure that results in death of the patient. Severity of liver disease depends primarily on the magnitude of the underlying intestinal problem that indicated PN. Transient ileus resulting from a non-intestinal disorder usually results in trivial, self-limited liver injury. Removal of a large segment of the intestinal tract because of necrotizing enterocolitis or a congenital malformation predicts a more prolonged course with a guarded prognosis, particularly when initially complicated by sepsis. Pathogenesis of PN-associated liver disease is not completely understood. There is no proven treatment short of ending PN through adaptation of remnant intestine or intestinal transplantation, with or without a concurrent liver graft. Effective interventions that are less radical than transplantation are needed. Research that includes prospective trials of novel therapies in PN-associated liver disease is the key to improving outcome.
More Related Videos
07:29Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure
Published on: August 14, 2017
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Portal Hypertension